Controlling biological activity with light: diarylethene-containing cyclic peptidomimetics.
about
Azobenzene Modified Imidacloprid Derivatives as Photoswitchable Insecticides: Steering Molecular Activity in a Controllable Manner.Therapeutic Potential of Gramicidin S in the Treatment of Root Canal Infections.Optical control of neuronal activity using a light-operated GIRK channel opener (LOGO).Inorganic nanoparticles engineered to attack bacteria.Emerging Targets in Photopharmacology.Macrocycles: lessons from the distant past, recent developments, and future directions.Fermentation and Cost-Effective 13C/15N Labeling of the Nonribosomal Peptide Gramicidin S for Nuclear Magnetic Resonance Structure Analysis.Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa.Photochromic coenzyme Q derivatives: switching redox potentials with light.The role of alkyl substituents in deazaadenine-based diarylethene photoswitchesDirect Photocontrol of Peptidomimetics: An Alternative to Oxygen-Dependent Photodynamic Cancer Therapy.Flexibility vs rigidity of amphipathic peptide conjugates when interacting with lipid bilayers.Photocontrol of Antibacterial Activity: Shifting from UV to Red Light Activation.Photochromism into nanosystems: towards lighting up the future nanoworld.Visible-Light-Triggered Activation of a Protein Kinase Inhibitor.Taking Photochromism beyond Visible: Direct One-Photon NIR Photoswitches Operating in the Biological Window.Internal Targeting and External Control: Phototriggered Targeting in Nanomedicine.Connectivity pattern modifies excited state relaxation dynamics of fluorophore-photoswitch molecular dyads.Dissociation of haemolytic and oligomer-preventing activities of gramicidin S derivatives targeting the amyloid-β N-terminus.Nucleoside-Based Diarylethene Photoswitches: Synthesis and Photochromic Properties.Azobenzene photocontrol of peptides and proteins.Photoactivated 2,3-distyrylindoles kill multi-drug resistant bacteria.Photoreversible prodrugs and protags: switching the release of maleimides by using light under physiological conditions.Photoswitchable membranes based on peptide-modified nanoporous anodic alumina: toward smart membranes for on-demand molecular transport.Photochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides.Azobenzene-benzoylphenylureas as photoswitchable chitin synthesis inhibitors.Bacterial patterning controlled by light exposure.Light flips a membrane-embedded helixMolecular Motors in Aqueous EnvironmentOptical Control of Antimicrobial Activity in Quinolone Derivatives
P2860
Q36120061-729D779F-09D2-4217-8EED-E81CC39B8F82Q37290856-E92FDCFF-EC9C-48CA-AF92-1640D6B27242Q37585109-100F0FDC-F007-414C-BF96-E0A8CAD4FE62Q38550551-6E2BB85F-80C8-4BCA-9615-BCE31F9D7A46Q38845495-96433E0D-1821-4894-8641-602935DEA624Q39065925-75372A9C-F0E6-4EFA-AFED-C1C9DDD0C01AQ40314789-33C3EE77-9F07-4580-9200-A16EFB936D1EQ41159517-502EF568-72B2-4618-B560-D491EDF7FAFBQ42278649-3AACA08A-7BA2-4A51-B18D-236BB50A6C2DQ42734836-F8CFE905-A5A3-472B-A6CF-A3AC4E3B49F7Q46571666-FD5E8255-7D15-4811-A9FA-541AA19F4F05Q47123982-40756A95-A352-48DA-A86B-4F25481CC32EQ47128488-EE3C0119-A465-4F3B-9B35-78C68ADDAD8EQ47240597-B031ADC9-70E8-4B46-BA27-638B4C15620AQ48050086-DF5267DC-253B-45F5-A6D1-9F354DEECE92Q48112136-B29A8DE4-1024-4DEE-9DFC-D02C9E5FA639Q48122048-082F22B1-2F77-479B-A99A-AC0A200673ADQ48330962-9EF552BE-E90E-4FDC-B6AD-DD74C76284BEQ49498937-F853F7AB-510B-4E3A-8AFA-40B828A92094Q50228924-6C72A09D-7CA6-446C-AC8A-2D9496EE4C48Q51562229-DFAF2AF1-F878-40D6-A798-40C1B9D37D77Q52576967-0E0B6243-62D8-484F-B51D-51400C64EA55Q52869988-FCAAF81B-CCD1-4AE9-BCF7-9CDC4887A81AQ53016334-AF95688E-5194-4185-A2A3-E889D3F157C4Q53272199-98B76978-0CB6-40F5-9811-35C265F9E435Q53389687-1CDA99E9-B807-4AA5-BD0F-D11ECCA6627DQ54276282-2B5450BD-63BD-4EFA-8E27-0348392ACD57Q57528299-DD13E3E1-7605-4270-AEF7-FB45BFED0057Q58717799-B4DC29A4-EF2F-48AE-8DEF-AE37ED50C853Q58799345-78244928-82A9-41CC-863A-3F3C579AE53C
P2860
Controlling biological activity with light: diarylethene-containing cyclic peptidomimetics.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Controlling biological activit ...... aining cyclic peptidomimetics.
@ast
Controlling biological activit ...... aining cyclic peptidomimetics.
@en
Controlling biological activit ...... aining cyclic peptidomimetics.
@nl
type
label
Controlling biological activit ...... aining cyclic peptidomimetics.
@ast
Controlling biological activit ...... aining cyclic peptidomimetics.
@en
Controlling biological activit ...... aining cyclic peptidomimetics.
@nl
prefLabel
Controlling biological activit ...... aining cyclic peptidomimetics.
@ast
Controlling biological activit ...... aining cyclic peptidomimetics.
@en
Controlling biological activit ...... aining cyclic peptidomimetics.
@nl
P2860
P50
P356
P1476
Controlling biological activit ...... aining cyclic peptidomimetics.
@en
P2093
Sabine Reiβer
Thomas Steinbrecher
P2860
P304
P356
10.1002/ANIE.201310019
P407
P50
P577
2014-02-19T00:00:00Z